Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0920646 (
renal ischemia
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Liver-type fatty acid-binding protein (L-FABP) is a biomarker for the early detection of renal diseases in humans. It is secreted along with cytotoxic oxidation products from proximal tubular epithelial cells under conditions of ischemia and/or oxidative stress. This study examined urinary L-
FABP
excretion under
renal ischemia
in feline acute kidney injury (AKI) model. L-
FABP
excretion increased immediately after
renal ischemia
/reperfusion, despite the absence of obvious structural damage to the kidneys, in the two AKI model cats studied. L-
FABP
was detected in the renal tubular lumen immediately after
renal ischemia
/reperfusion in the two cats, but not in a sham surgery cat. These results suggested that high L-
FABP
excretion is a pathophysiological response associated with antioxidant defense in proximal tubules with
renal ischemia
and/or oxidative stress in a feline model.
...
PMID:Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study. 3164 5